14-3-3σ Expression and prognostic value in patients with epithelial ovarian carcinoma: A high throughput tissue microarray analysis
- 31 July 2009
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (7) , 763-767
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Clinical Importance of Ki-67, p16, p14, and p57 Expression in Patients With Advanced Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2007
- Expression and Prognostic Significance of Cyclin D3 in Ovarian AdenocarcinomasInternational Journal of Gynecological Pathology, 2007
- Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Gynecologic Oncology, 2007
- 14-3-3 proteins in cell cycle regulationSeminars in Cancer Biology, 2006
- 14-3-3 proteins as potential oncogenesSeminars in Cancer Biology, 2006
- Stat Bite: Age-Specific Incidence and Mortality Rates for Ovarian Cancer, 1998–2002JNCI: Journal of the National Cancer Institute, 2006
- The 14-3-3 cancer connectionNature Reviews Cancer, 2003
- Reduced retinoblastoma gene protein to ki-67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patientsGynecologic Oncology, 2003
- The Combined Evaluation of p27Kip1 and Ki-67 Expression Provides Independent Information on Overall Survival of Ovarian Carcinoma PatientsGynecologic Oncology, 2002